{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:39:58Z","timestamp":1790750398479,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gallbladder stones (GS) is associated with an increased risk of cardiovascular disease. However, the relationship between cholecystectomy for GS and acute coronary syndrome (ACS) is unknown. We investigated the ACS risk in patients with GS and its association with cholecystectomy. Data from the Korean National Health Insurance Service-National Sample Cohort from 2002 to 2013 was extracted. Overall, 64,370 individuals were selected through a 1:3 propensity score matching. Patients were stratified into two groups for comparison: the gallstone group, GS patients with or without cholecystectomy; and the control group, patients without GS or cholecystectomy. The gallstone group exhibited a higher risk of ACS than the control group (hazard ratio [HR], 1.30; 95% confidence interval [CI] 1.15\u20131.47;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). In the gallstone group, individuals without cholecystectomy had a higher risk of ACS development (HR: 1.35, 95% CI 1.17\u20131.55,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Patients with GS with diabetes, hypertension, or dyslipidemia, had a higher risk of developing ACS than GS patients without the metabolic diseases (HR: 1.29,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). The risk did not significantly differ after cholecystectomy compared to those without GS (HR: 1.15,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.1924), but without cholecystectomy, the risk of ACS development was significantly higher than control group (1.30, 95% CI 1.13\u20131.50,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.0004). Among patients without above metabolic disorders, cholecystectomy was still associated with increased ACS risk in the gallstone group (HR: 2.93, 95% CI 1.27\u20136.76,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.0116). GS increased the risk of ACS. The effect of cholecystectomy on ACS risk differs according to the presence or absence of metabolic disorders. Thus, the decision to perform cholecystectomy for GS should consider both the ACS risk and the underlying disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-33440-4","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:02:59Z","timestamp":1683266579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study"],"prefix":"10.1038","volume":"13","author":[{"given":"Wonjeong","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hyun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Jae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmin","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-In","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Youp","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"33440_CR1","first-page":"11283","volume":"8","author":"Y Froutan","year":"2015","unstructured":"Froutan, Y. et al. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int. J. Clin. Exp. Med. 8, 11283\u201311288 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"33440_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","volume":"20","author":"EA Shaffer","year":"2006","unstructured":"Shaffer, E. A. Epidemiology of gallbladder stone disease. Best Pract. Res. Clin. Gastroenterol. 20, 981\u2013996. https:\/\/doi.org\/10.1016\/j.bpg.2006.05.004 (2006).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"33440_CR3","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/cphy.c150050","volume":"6","author":"C Housset","year":"2016","unstructured":"Housset, C., Chretien, Y., Debray, D. & Chignard, N. Functions of the gallbladder. Compr. Physiol. 6, 1549\u20131577. https:\/\/doi.org\/10.1002\/cphy.c150050 (2016).","journal-title":"Compr. Physiol."},{"key":"33440_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42327-2","author":"CJ Fairfield","year":"2019","unstructured":"Fairfield, C. J., Wigmore, S. J. & Harrison, E. M. Gallstone disease and the risk of cardiovascular disease. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-019-42327-2 (2019).","journal-title":"Sci. Rep."},{"key":"33440_CR5","doi-asserted-by":"publisher","first-page":"e76448","DOI":"10.1371\/journal.pone.0076448","volume":"8","author":"MT Olaiya","year":"2013","unstructured":"Olaiya, M. T., Chiou, H. Y., Jeng, J. S., Lien, L. M. & Hsieh, F. I. Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study. Plos One 8, e76448 (2013).","journal-title":"Plos One"},{"key":"33440_CR6","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/ATVBAHA.116.307507","volume":"36","author":"Y Zheng","year":"2016","unstructured":"Zheng, Y. et al. Gallstones and risk of coronary heart disease: prospective analysis of 270 000 men and women from 3 US cohorts and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 36, 1997\u20132003. https:\/\/doi.org\/10.1161\/ATVBAHA.116.307507 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33440_CR7","doi-asserted-by":"publisher","first-page":"15104","DOI":"10.1038\/s41598-017-15430-5","volume":"7","author":"LL Fan","year":"2017","unstructured":"Fan, L. L., Chen, B. H. & Dai, Z. J. The relation between gallstone disease and cardiovascular disease. Sci. Rep. 7, 15104. https:\/\/doi.org\/10.1038\/s41598-017-15430-5 (2017).","journal-title":"Sci. Rep."},{"key":"33440_CR8","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380, 2095\u20132128. https:\/\/doi.org\/10.1016\/S0140-6736(12)61728-0 (2012).","journal-title":"The Lancet"},{"key":"33440_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1665-2681(19)31490-5","volume":"11","author":"NC Chavez-Tapia","year":"2012","unstructured":"Chavez-Tapia, N. C. et al. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann. Hepatol. 11, 85\u201389. https:\/\/doi.org\/10.1016\/S1665-2681(19)31490-5 (2012).","journal-title":"Ann. Hepatol."},{"key":"33440_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/00325481.2020.1846964","volume":"133","author":"CH Chen","year":"2021","unstructured":"Chen, C. H., Lin, C. L. & Kao, C. H. The effect of cholecystectomy on the risk of acute myocardial infarction in patients with gallbladder stones. Postgrad. Med. 133, 209\u2013216. https:\/\/doi.org\/10.1080\/00325481.2020.1846964 (2021).","journal-title":"Postgrad. Med."},{"key":"33440_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/labinvest.2017.95","volume":"98","author":"YS Chen","year":"2018","unstructured":"Chen, Y. S., Wu, S. D. & Tian, Y. Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms. Lab. Invest. 98, 7\u201314. https:\/\/doi.org\/10.1038\/labinvest.2017.95 (2018).","journal-title":"Lab. Invest."},{"key":"33440_CR12","first-page":"47","volume":"105","author":"C Fairfield","year":"2018","unstructured":"Fairfield, C., Wigmore, S. & Harrison, E. Gallstone disease and the risk of cardiovascular disease: systematic review and meta-analysis of observational studies. Brit. J. Surg. 105, 47\u201347 (2018).","journal-title":"Brit. J. Surg."},{"key":"33440_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s13410-019-00748-9","volume":"40","author":"JJ Huang","year":"2020","unstructured":"Huang, J. J. et al. The association between gallstone disease (GSD) and the incidence of prediabetes and type 2 diabetes mellitus (type 2 DM): a prospective cohort study. Int. J. Diabetes Dev. C 40, 40\u201346. https:\/\/doi.org\/10.1007\/s13410-019-00748-9 (2020).","journal-title":"Int. J. Diabetes Dev. C"},{"key":"33440_CR14","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","volume":"2","author":"F Lammert","year":"2016","unstructured":"Lammert, F. et al. Gallstones. Nat. Rev. Dis. Primers 2, 16024. https:\/\/doi.org\/10.1038\/nrdp.2016.24 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"33440_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/s0140-6736(06)69044-2","volume":"368","author":"P Portincasa","year":"2006","unstructured":"Portincasa, P., Moschetta, A. & Palasciano, G. Cholesterol gallstone disease. Lancet 368, 230\u2013239. https:\/\/doi.org\/10.1016\/s0140-6736(06)69044-2 (2006).","journal-title":"Lancet"},{"key":"33440_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1478-3231.2010.02361.x","volume":"31","author":"L Amigo","year":"2011","unstructured":"Amigo, L. et al. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int. 31, 52\u201364. https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02361.x (2011).","journal-title":"Liver Int."},{"key":"33440_CR17","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","volume":"50","author":"PB Hylemon","year":"2009","unstructured":"Hylemon, P. B. et al. Bile acids as regulatory molecules. J. Lipid Res. 50, 1509\u20131520 (2009).","journal-title":"J. Lipid Res."},{"key":"33440_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrendo.2014.60","volume":"10","author":"F Kuipers","year":"2014","unstructured":"Kuipers, F., Bloks, V. W. & Groen, A. K. Beyond intestinal soap\u2013bile acids in metabolic control. Nat. Rev. Endocrinol. 10, 488\u2013498. https:\/\/doi.org\/10.1038\/nrendo.2014.60 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"33440_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10620-019-05823-z","volume":"65","author":"I Sergeev","year":"2020","unstructured":"Sergeev, I., Keren, N., Naftali, T. & Konikoff, F. M. Cholecystectomy and biliary sphincterotomy increase fecal bile loss and improve lipid profile in dyslipidemia. Dig. Dis. Sci. 65, 1223\u20131230. https:\/\/doi.org\/10.1007\/s10620-019-05823-z (2020).","journal-title":"Dig. Dis. Sci."},{"key":"33440_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/gut.5.6.607","volume":"5","author":"A Krondl","year":"1964","unstructured":"Krondl, A., Vavrinkova, H. & Michalec, C. effect of cholecystectomy on the role of the gall bladder in fat absorption. Gut 5, 607\u2013610. https:\/\/doi.org\/10.1136\/gut.5.6.607 (1964).","journal-title":"Gut"},{"key":"33440_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/jci115961","volume":"90","author":"F Berr","year":"1992","unstructured":"Berr, F., Pratschke, E., Fischer, S. & Paumgartner, G. Disorders of bile acid metabolism in cholesterol gallstone disease. J. Clin. Invest. 90, 859\u2013868. https:\/\/doi.org\/10.1172\/jci115961 (1992).","journal-title":"J. Clin. Invest."},{"key":"33440_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363. https:\/\/doi.org\/10.1038\/nature09922 (2011).","journal-title":"Nature"},{"key":"33440_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/eurheartj\/eht467","volume":"35","author":"S Vinj\u00e9","year":"2014","unstructured":"Vinj\u00e9, S., Stroes, E., Nieuwdorp, M. & Hazen, S. L. The gut microbiome as novel cardio-metabolic target: the time has come!. Eur. Heart J. 35, 883\u2013887. https:\/\/doi.org\/10.1093\/eurheartj\/eht467 (2014).","journal-title":"Eur. Heart J."},{"key":"33440_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang, W. H. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575\u20131584. https:\/\/doi.org\/10.1056\/NEJMoa1109400 (2013).","journal-title":"N. Engl. J. Med."},{"key":"33440_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585. https:\/\/doi.org\/10.1038\/nm.3145 (2013).","journal-title":"Nat. Med."},{"key":"33440_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1756283x10388682","volume":"4","author":"G Charach","year":"2011","unstructured":"Charach, G. et al. The association of bile acid excretion and atherosclerotic coronary artery disease. Therap. Adv. Gastroenterol. 4, 95\u2013101. https:\/\/doi.org\/10.1177\/1756283x10388682 (2011).","journal-title":"Therap. Adv. Gastroenterol."},{"key":"33440_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/1471-2164-14-669","volume":"14","author":"T Wu","year":"2013","unstructured":"Wu, T. et al. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genom. 14, 669. https:\/\/doi.org\/10.1186\/1471-2164-14-669 (2013).","journal-title":"BMC Genom."},{"key":"33440_CR28","doi-asserted-by":"publisher","first-page":"31s","DOI":"10.1002\/hep.1840040806","volume":"4","author":"MC Carey","year":"1984","unstructured":"Carey, M. C. & Mazer, N. A. Biliary lipid secretion in health and in cholesterol gallstone disease. Hepatology 4, 31s\u201337s. https:\/\/doi.org\/10.1002\/hep.1840040806 (1984).","journal-title":"Hepatology"},{"key":"33440_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1758-2229.12319","volume":"7","author":"N Keren","year":"2015","unstructured":"Keren, N. et al. Interactions between the intestinal microbiota and bile acids in gallstones patients. Environ. Microbiol. Rep. 7, 874\u2013880. https:\/\/doi.org\/10.1111\/1758-2229.12319 (2015).","journal-title":"Environ. Microbiol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33440-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:16:34Z","timestamp":1683267394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33440-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33440"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33440-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7300"}}